Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lazarus

Showing results (681-690 of 1,048) with videos related to

Pageof 105
Sort By:
Leukemia|January 1, 1992
Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology GroupP A Cassileth, J W Andersen, J M Bennett, et al.
American Journal of Hematology|June 19, 2009
Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplantPaul M Barr, Hillard M Lazarus, Brenda W Cooper, et al.
Oncotarget|November 8, 2017
Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignanciesPaolo F Caimi, Brenda W Cooper, Basem M William, et al.
Seminars in Oncology|June 1, 1985
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiationR H Herzig, P F Coccia, H M Lazarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow TransplantationPhilip J Bierman, John W Sweetenham, Fausto R Loberiza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2010
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based reviewDenise M Oliansky, Myron Czuczman, Richard I Fisher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2010
Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemiaCollin C Barker, Manza-A Agovi, Brent Logan, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1975
The effects of varying dialysis regimens on lymphocyte stimulationK S Hurst, L F Saldanha, S M Steinberg, et al.
Bone Marrow Transplantation|July 20, 2006
Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilizationP Fu, R K Bagai, H Meyerson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
Peritransplant use of ultraviolet-B irradiation (UV-B) therapy is detrimental to allogeneic stem cell transplantation outcomeMeltem Yüksel, Elma Baron, Melissa Camouse, et al.
Pageof 105

Showing results (681-690 of 1,048) with videos related to

Sort By:
Pageof 105
Leukemia|January 1, 1992
Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology GroupP A Cassileth, J W Andersen, J M Bennett, et al.
American Journal of Hematology|June 19, 2009
Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplantPaul M Barr, Hillard M Lazarus, Brenda W Cooper, et al.
Oncotarget|November 8, 2017
Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignanciesPaolo F Caimi, Brenda W Cooper, Basem M William, et al.
Seminars in Oncology|June 1, 1985
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiationR H Herzig, P F Coccia, H M Lazarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow TransplantationPhilip J Bierman, John W Sweetenham, Fausto R Loberiza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2010
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based reviewDenise M Oliansky, Myron Czuczman, Richard I Fisher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2010
Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemiaCollin C Barker, Manza-A Agovi, Brent Logan, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1975
The effects of varying dialysis regimens on lymphocyte stimulationK S Hurst, L F Saldanha, S M Steinberg, et al.
Bone Marrow Transplantation|July 20, 2006
Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilizationP Fu, R K Bagai, H Meyerson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
Peritransplant use of ultraviolet-B irradiation (UV-B) therapy is detrimental to allogeneic stem cell transplantation outcomeMeltem Yüksel, Elma Baron, Melissa Camouse, et al.
Pageof 105